Effectiveness of Mindfulness-Based Intervention in Reducing Stigma Stress Among Parents of Autistic Children

NCT ID: NCT06975163

Last Updated: 2025-05-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

51 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-01

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Autism Spectrum Disorder (ASD) is a lifelong neurodevelopmental condition that usually becomes apparent in early childhood. Those diagnosed with ASD commonly struggle with social communication and behavioral regulation, often facing widespread societal stigma across different cultures. This prejudice extends beyond the affected children to their parents, who are routinely subjected to baseless blame and viewed as incapable of proper parenting. Such persistent negative perceptions can foster profound emotional suffering and chronic stress linked to societal judgment.

To date, there are no empirically supported interventions specifically aimed at alleviating stigma-induced stress in parents of autistic children. Nevertheless, studies in related fields indicate that mindfulness-based strategies could offer a potential coping mechanism. Addressing this gap, the current research presents a newly developed 4-week Mindfulness-Based Stigma Stress Reduction (MBSSR) program tailored for these parents. Using a randomized controlled trial, participants were divided into an MBSSR group or a waitlist control group, with both undergoing standardized evaluations at three distinct time points.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Autism Spectrum Disorder (ASD) is a well-known neurodevelopmental condition that emerges in early childhood and continues into adulthood. Children with ASD frequently face social and behavioral difficulties, and research indicates that stigma surrounding autism is prevalent in many societies. These children are sometimes mistakenly perceived as deliberately unruly, resulting in social prejudice and exclusion. This stigma also affects their parents, who endure societal judgment due to their emotional and biological ties to their children. Parents may be wrongly blamed for passing on "faulty" genes or accused of causing their child's condition. Additionally, they are often labeled as incompetent caregivers and criticized for failing to properly handle their child's behavior. Prolonged exposure to such bias can trigger deep-seated shame and psychological distress, leading to persistent stress linked to stigma.

Although stigma-related stress significantly impacts parents of autistic children, there are currently no scientifically validated interventions specifically designed to help them manage it. However, studies in similar areas propose that mindfulness practices may help individuals deal with stigma-induced stress. To bridge this research gap, this study introduces a novel 4-week Mindfulness-Based Stigma Stress Reduction (MBSSR) program tailored for parents of children with autism in Hong Kong. Using a randomized controlled trial approach, participants were divided into either the MBSSR treatment group or a waitlist control group, with both groups undergoing standardized evaluations at three separate intervals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mindfulness-Based Stigma Stress Reduction (MBSSR) group

Participants in the MBSSR group received a 4-week MBSSR program immediately after randomization. Participants completed the post-intervention assessment right after the intervention and the follow-up assessment one month after the intervention.

Group Type EXPERIMENTAL

Mindfulness-Based Stigma Stress Reduction (MBSSR) program

Intervention Type BEHAVIORAL

The MBSSR program was developed by modifying elements from the Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT) programs to create a distinct mindfulness intervention targeted at alleviating stigma stress among parents of autistic children. This program consisted of four group sessions, each incorporating mindfulness practices, group discussions, and activities that helped participants apply mindfulness principles to their daily lives.

Waitlist control group

Participants in the waitlist control group waited for 4 weeks without the Mindfulness-Based Stigma Stress Reduction (MBSSR) program. Participants completed the post-intervention assessment and the follow-up assessment simultaneously with the MBSSR group. After completing the follow-up assessment, the waitlist control participants started the MBSSR program (equivalent to that of the MBSSR group).

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mindfulness-Based Stigma Stress Reduction (MBSSR) program

The MBSSR program was developed by modifying elements from the Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT) programs to create a distinct mindfulness intervention targeted at alleviating stigma stress among parents of autistic children. This program consisted of four group sessions, each incorporating mindfulness practices, group discussions, and activities that helped participants apply mindfulness principles to their daily lives.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having a child formally diagnosed with Autism Spectrum Disorder (ASD) under Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) criteria by a registered medical practitioner
* Acting as the principal caregiver for the child
* Having the ability to read and write in Chinese
* Demonstrating the experience of stigma stress on the Family Stigma Stress Scale, defined as agreeing with item(s) that gauge perceived stigma harm and disagreeing with item(s) that evaluate perceived coping resources

Exclusion Criteria

* Having participated in any mindfulness-based programs before
* Currently using psychiatric medications or receiving mental health services from professionals
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Education University of Hong Kong

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

CHAN Ka Shing Kevin

Professor, Head of Department of Psychology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kevin Ka Shing Chan

Role: PRINCIPAL_INVESTIGATOR

The Education University of Hong Kong

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Education University of Hong Kong

Hong Kong, , Hong Kong

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Hong Kong

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-2021-0126

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.